Bookmark
Forward
Encorafenib (Braftovi) for metastatic colorectal cancer.
The Medical letter on drugs and therapeutics 2021 Jan 25
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Encorafenib (Braftovi) for metastatic colorectal cancer.
The Medical letter on drugs and therapeutics.
2021 Jan 25;63(1616):15-16
Mesh Tags
Antineoplastic Combined Chemotherapy Protocols
Carbamates
Cetuximab
Clinical Trials as Topic
Colorectal Neoplasms
Humans
Proto-Oncogene Proteins B-raf
Sulfonamides
Substances
Carbamates
Sulfonamides
encorafenib
BRAF protein, human
Proto-Oncogene Proteins B-raf
Cetuximab
PMID: 33512348
View Full Text